Perrigo Reports Record Sales and Earnings for Third Quarter F...( - Third quarter revenue increased ...),Health

- Third quarter revenue increased $141 million, or 39 percent, to $504

million on important new product launches - GAAP net income increased 134 percent to $40 million, or $0.42 per share - Adjusted net income increased 100 percent to $44 million, or $0.47 per

share - Refined full year fiscal 2008 adjusted earnings guidance to be in a range of $1.55 to $1.60 per share, with a tax rate in a range of 23% to 27%

ALLEGAN, Mich., May 6 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced results for its third quarter fiscal year 2008 and nine months ended March 29, 2008.

Perrigo Company

(in thousands, except per share amounts)

Third Quarter Nine Months

2008 2007 2008 2007

Net Sales $503,707 $362,288 $1,321,930 $1,073,132

Net Income $39,967 $17,056 $108,275 $55,026

Adjusted Net Income $44,264 $22,082 $112,572 $60,470

Diluted EPS $0.42 $0.18 $1.14 $0.59

Adjusted Diluted EPS $0.47 $0.24 $1.18 $0.65

Diluted Shares 94,955 93,298 95,115 93,604

These reported results include an acquisition-related write-off of the in- process research and development (IPR&D) of $2.0 million after-tax and a charge for the write-off of the step-up of inventory acquired of $2.1 million after-tax, both related to our January 9, 2008 acquisition of Galpharm Healthcare, Ltd., a leading supplier of over-the-counter store brand pharmaceuti
'/>"/>